Literature DB >> 22717771

Lymph node vascular-stromal growth and function as a potential target for controlling immunity.

Fairouz Benahmed1, Scott Ely, Theresa T Lu.   

Abstract

Lymphadenopathy occurs in many autoimmune and inflammatory diseases, and vascular proliferation is a common feature in the enlarged lymph nodes. The lymph node vasculature plays critical roles in delivering immune cells as well as oxygen and micronutrients, and therefore represents a potential target for therapeutic manipulation of immunity. In this review, we discuss recent insights made in understanding the growth and function of the vascular and associated stromal compartment in immune-stimulated lymph nodes and the potential utility of altering this process in autoimmune diseases.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22717771      PMCID: PMC3932544          DOI: 10.1016/j.clim.2012.05.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  57 in total

Review 1.  Homing and cellular traffic in lymph nodes.

Authors:  Ulrich H von Andrian; Thorsten R Mempel
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

Review 2.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.

Authors:  Jason G Cyster; Susan R Schwab
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

3.  Coordinated regulation of lymph node vascular-stromal growth first by CD11c+ cells and then by T and B cells.

Authors:  Susan Chyou; Fairouz Benahmed; Jingfeng Chen; Varsha Kumar; Sha Tian; Martin Lipp; Theresa T Lu
Journal:  J Immunol       Date:  2011-10-26       Impact factor: 5.422

4.  Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases.

Authors:  M Kojima; S Nakamura; Y Morishita; H Itoh; K Yoshida; Y Ohno; T Oyama; S Asano; T Joshita; S Mori; T Suchi; N Masawa
Journal:  Pathol Int       Date:  2000-04       Impact factor: 2.534

5.  Increased plasma cell frequency and accumulation of abnormal syndecan-1plus T-cells in Igmu-deficient/lpr mice.

Authors:  Jane Seagal; Nira Leider; Gizi Wildbaum; Nathan Karin; Doron Melamed
Journal:  Int Immunol       Date:  2003-09       Impact factor: 4.823

6.  Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy.

Authors:  Y K Jeon; J H Paik; S-S Park; S O Park; Y A Kim; J E Kim; Y W Song; C W Kim
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

7.  Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  M Calgüneri; M A Oztürk; Z Ozbalkan; A Akdogan; K Ureten; S Kiraz; I Ertenli
Journal:  J Int Med Res       Date:  2003 Jul-Aug       Impact factor: 1.671

8.  Regulation of T cell priming by lymphoid stroma.

Authors:  Omar Khan; Mark Headley; Audrey Gerard; Wei Wei; Limin Liu; Matthew F Krummel
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

9.  Normalization of the lymph node T cell stromal microenvironment in lpr/lpr mice is associated with SU5416-induced reduction in autoantibodies.

Authors:  Susan Chyou; Sha Tian; Eric H Ekland; Theresa T Lu
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

10.  Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide.

Authors:  Stefanie Siegert; Hsin-Ying Huang; Chen-Ying Yang; Leonardo Scarpellino; Lucie Carrie; Sarah Essex; Peter J Nelson; Matthias Heikenwalder; Hans Acha-Orbea; Christopher D Buckley; Benjamin J Marsland; Dietmar Zehn; Sanjiv A Luther
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

View more
  7 in total

1.  The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis.

Authors:  P Ruscitti; F Ciccia; P Cipriani; G Guggino; P Di Benedetto; A Rizzo; V Liakouli; O Berardicurti; F Carubbi; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2015-12-08       Impact factor: 4.330

Review 2.  Regulation of Lymph Node Vascular-Stromal Compartment by Dendritic Cells.

Authors:  Dragos C Dasoveanu; William D Shipman; Jennifer J Chia; Susan Chyou; Theresa T Lu
Journal:  Trends Immunol       Date:  2016-09-13       Impact factor: 16.687

3.  Multiple CD11c+ cells collaboratively express IL-1β to modulate stromal vascular endothelial growth factor and lymph node vascular-stromal growth.

Authors:  Fairouz Benahmed; Susan Chyou; Dragos Dasoveanu; Jingfeng Chen; Varsha Kumar; Yoichiro Iwakura; Theresa T Lu
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

4.  Optical projection tomography reveals dynamics of HEV growth after immunization with protein plus CFA and features shared with HEVs in acute autoinflammatory lymphadenopathy.

Authors:  Varsha Kumar; Susan Chyou; Jens V Stein; Theresa T Lu
Journal:  Front Immunol       Date:  2012-09-07       Impact factor: 7.561

5.  Ischemia and reperfusion injury in superficial inferior epigastric artery-based vascularized lymph node flaps.

Authors:  David P Perrault; Gene K Lee; Antoun Bouz; Cynthia Sung; Roy Yu; Austin J Pourmoussa; Sun Young Park; Gene H Kim; Wan Jiao; Ketan M Patel; Young-Kwon Hong; Alex K Wong
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

6.  The Lymphatic Endothelial mCLCA1 Antibody Induces Proliferation and Growth of Lymph Node Lymphatic Sinuses.

Authors:  Kimberly L Jordan-Williams; Neela Ramanujam; Andrew G Farr; Alanna Ruddell
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

7.  Organ-wide 3D-imaging and topological analysis of the continuous microvascular network in a murine lymph node.

Authors:  Inken D Kelch; Gib Bogle; Gregory B Sands; Anthony R J Phillips; Ian J LeGrice; P Rod Dunbar
Journal:  Sci Rep       Date:  2015-11-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.